IMI-PainCare is a large multi-stakeholder consortium funded via the Innovative Medicines Initiative 2 programme, which receives funding from the European Commission and the pharmaceutical industry. IMI-PainCare aims to develop alignment on patient reported outcomes used in pain research, identification of biomarkers for pain, and the refinement of preclinical models for improved translational pain research.
EFIC is one of three scientific societies contributing to the project. EFIC leads on communication activities, disseminating the results of the project to the wider scientific community and general public, providing strategic communication advice and leading on content development such as webinars and lay summaries.
IMI-Pain Care Interview: BioPain
Find out more about BioPain in the video below.
IMI-Pain Care Interview: PROMPT
Find out more about PROMPT in the video below.
IMI-Pain Care Interview: TRIPP
Find out more about TRIPP in the video below
